| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| Coexpression | DARWICHE_PAPILLOMA_RISK_LOW_DN | 2.55e-04 | 172 | 4 | 2 | M1134 | |
| Coexpression | DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN | 2.98e-04 | 186 | 4 | 2 | M1140 | |
| Coexpression | DARWICHE_PAPILLOMA_RISK_LOW_DN | 2.98e-04 | 186 | 4 | 2 | MM498 | |
| Coexpression | GSE13411_NAIVE_BCELL_VS_PLASMA_CELL_UP | 3.31e-04 | 196 | 4 | 2 | M3243 | |
| Coexpression | GSE17721_LPS_VS_GARDIQUIMOD_0.5H_BMDC_UP | 3.41e-04 | 199 | 4 | 2 | M4037 | |
| Coexpression | DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN | 3.48e-04 | 201 | 4 | 2 | MM502 | |
| Coexpression | JIANG_MELANOMA_TRM8_CD4 | 1.55e-03 | 426 | 4 | 2 | M48972 | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD8-Trm_gut_CD8|bone_marrow / Manually curated celltypes from each tissue | 6.68e-05 | 151 | 4 | 2 | 5eebdc7ad6af3cc0263e4d8c3516818305ac38f2 | |
| ToppCell | Bac-SEP-Lymphocyte-T_NK-CD4_TEM|Bac-SEP / Disease, Lineage and Cell Type | 7.13e-05 | 156 | 4 | 2 | ef6bad99bcb30956863cd490c613e251f3b27ba0 | |
| ToppCell | IIH-CD4-exh_CD4|IIH / Condition, Cell_class and T cell subcluster | 9.50e-05 | 180 | 4 | 2 | 31f22960819bfad79cbbd3b10c5dc46d7a47e340 | |
| ToppCell | BLOOD-unannotated|BLOOD / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 9.61e-05 | 181 | 4 | 2 | 3a5c0c701fc2c078e1504bbf88ae708546cc74a3 | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.01e-04 | 186 | 4 | 2 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 187 | 4 | 2 | 91c8e93bde0d1d1a4e324b0acf2afda00f4fb3bf | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-04 | 187 | 4 | 2 | 382db691eb0b3e089e816bed3d6699cc2d4e1bda | |
| ToppCell | Mild/Remission-B_intermediate-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.04e-04 | 188 | 4 | 2 | 614032d18f8060bb12d1af7a1cf1cf4d8b2b505b | |
| ToppCell | droplet-Spleen-nan-3m-Lymphocytic-B_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.04e-04 | 188 | 4 | 2 | 8b1485e63cd4020ba5334a8d4b84725b164549bf | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_T-T4_em-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 1.06e-04 | 190 | 4 | 2 | f6616b3fe7f4962249503c96c06926240066d861 | |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | 1.09e-04 | 193 | 4 | 2 | 7256a5a491536c525b31ae96d47ab5c6303cb73a | |
| ToppCell | BLOOD--(1)_MAIT-like_CD8_T_cells| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.10e-04 | 194 | 4 | 2 | 0064bcd9ac2fecec81f8d4e7d9f86f0089872fe7 | |
| ToppCell | 356C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.13e-04 | 196 | 4 | 2 | fe90501010128b72e6711c567cb04b012f1520a4 | |
| ToppCell | MNPs-Macrophages|MNPs / lung cells shred on cell class, cell subclass, sample id | 1.14e-04 | 197 | 4 | 2 | 03d74643646dce5d3a278a1ee48c390d13a7889c | |
| ToppCell | COVID-CD4-exh_CD4|COVID / Condition, Cell_class and T cell subcluster | 1.14e-04 | 197 | 4 | 2 | 39ee4b93625c994813044d8dd8854fba2bd99940 | |
| ToppCell | LAM-Myeloid-Macrophage|Myeloid / Condition, Lineage and Cell class | 1.14e-04 | 197 | 4 | 2 | 355fe286609df2ded973952f1856bbc5f437cfd0 | |
| ToppCell | normal_Lung-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass | 1.15e-04 | 198 | 4 | 2 | 189b787d51985b13d645bdb64def2de0a214d55b | |
| ToppCell | Severe-B_intermediate-0|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.15e-04 | 198 | 4 | 2 | c073281c7f9bb6062449c75b4ace4d54b866a33e | |
| ToppCell | 343B-Myeloid-Macrophage-FABP4+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-04 | 198 | 4 | 2 | d18270f45f170a8da6105f1c212cada6aab75412 | |
| ToppCell | 390C-Myeloid-Macrophage-FABP4+_Macrophage_2|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.15e-04 | 198 | 4 | 2 | 8a4b4bb6839b9ec52ff0b9c7b39cec8d9a9525bd | |
| ToppCell | Mild/Remission-B_intermediate-0|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.16e-04 | 199 | 4 | 2 | 592111591f0f6816fc56620cb555eb48dabf0758 | |
| ToppCell | Healthy/Control|World / Disease group and Cell class | 1.16e-04 | 199 | 4 | 2 | 2623c42b3e79e401a485879b52e8bbcbc581544d | |
| ToppCell | Control-Control-Lymphocyte-T/NK-CD4+_CTL|Control / Disease, condition lineage and cell class | 1.16e-04 | 199 | 4 | 2 | e8db312f392811ad79a43bf982fdb8c5805139bf | |
| ToppCell | Control-Myeloid-TRAM1|Myeloid / Condition, Lineage and Cell class | 1.16e-04 | 199 | 4 | 2 | 664f5cab3fe5ab599d1944deed04857ae14a06d5 | |
| ToppCell | MS-IIF-Lymphocyte-T/NK-CD4+_Tcm|IIF / Disease, condition lineage and cell class | 1.17e-04 | 200 | 4 | 2 | f5c570a03eac54a81921630c79f5bccab05d3452 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid-CD4/CD8|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.17e-04 | 200 | 4 | 2 | bb05d2d10c924202f78fa1bd271f60cbbf224108 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Lymphoid|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.17e-04 | 200 | 4 | 2 | e642b3e25b2884b2bc6114683fa7ac39d6559bf8 | |
| Computational | Genes in the cancer module 26. | 1.09e-03 | 207 | 3 | 2 | MODULE_26 | |
| Computational | Genes in the cancer module 207. | 1.30e-03 | 226 | 3 | 2 | MODULE_207 | |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Down 200; 7.2uM; MCF7; HT_HG-U133A | 4.20e-04 | 192 | 4 | 2 | 3612_DN | |
| Drug | AG-013608 [351320-38-2]; Down 200; 10uM; PC3; HT_HG-U133A | 4.24e-04 | 193 | 4 | 2 | 5909_DN | |
| Drug | Caffeic acid [3331-39-5]; Down 200; 22.2uM; PC3; HT_HG-U133A | 4.24e-04 | 193 | 4 | 2 | 6753_DN | |
| Drug | SC-560; Down 200; 10uM; MCF7; HT_HG-U133A | 4.29e-04 | 194 | 4 | 2 | 6913_DN | |
| Drug | Methoxy-8-psoralen [298-81-7]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 4.33e-04 | 195 | 4 | 2 | 5007_UP | |
| Drug | Acetohexamide [968-81-0]; Up 200; 12.4uM; HL60; HT_HG-U133A | 4.33e-04 | 195 | 4 | 2 | 1870_UP | |
| Drug | Doxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; HL60; HT_HG-U133A | 4.37e-04 | 196 | 4 | 2 | 2737_DN | |
| Drug | ICI 182,780; Down 200; 1uM; HL60; HT_HG-U133A | 4.37e-04 | 196 | 4 | 2 | 1146_DN | |
| Drug | Homosalate [118-56-9]; Down 200; 15.2uM; PC3; HT_HG-U133A | 4.42e-04 | 197 | 4 | 2 | 3797_DN | |
| Drug | Bacampicillin hydrochloride [37661-08-8]; Down 200; 8uM; HL60; HT_HG-U133A | 4.51e-04 | 199 | 4 | 2 | 1337_DN | |
| Drug | Carbamazepine [298-46-4]; Up 200; 17uM; HL60; HT_HG-U133A | 4.51e-04 | 199 | 4 | 2 | 1847_UP | |
| Drug | Ebselen [60940-34-3]; Down 200; 14.6uM; HL60; HT_HG-U133A | 4.51e-04 | 199 | 4 | 2 | 2717_DN | |
| Drug | Iopamidol [60166-93-0]; Down 200; 5.2uM; HL60; HT_HG-U133A | 4.51e-04 | 199 | 4 | 2 | 2732_DN | |
| Drug | Air Pollutants | 9.21e-03 | 917 | 4 | 2 | ctd:D000393 | |
| Drug | nimesulide | 1.56e-02 | 1202 | 4 | 2 | ctd:C012655 | |
| Disease | serum gamma-glutamyl transferase measurement | 5.52e-03 | 914 | 4 | 2 | EFO_0004532 | |
| Disease | diet measurement | 7.22e-03 | 1049 | 4 | 2 | EFO_0008111 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PGHWWASFFFGKSTL | 51 | Q9H3Y8 | |
| ITCGKSHIFFWTWSG | 426 | Q9HC35 | |
| FNALTGWASSRFGWF | 101 | Q7Z5S9 | |
| HTKSSGFGWFSWFRS | 906 | Q96JE7 | |
| GFGWFSWFRSKPTKN | 911 | Q96JE7 |